Recent news on Risperdal Consta

Johnson & Johnson wins on blocking rival generic version of its drug  -  May 11, 2007
Asbury Park Press,Risperdal and the related Risperdal Consta generated $4.2 billion in sales last year for Johnson & Johnson. Of that, $2.4 billion was in the US

New Dosing Option Approved for Risperdal Consta  -  Apr 17, 2007
Facts and Comparisons,The FDA has approved Janssen’s Risperdal Consta (risperidone) 12.5 mg long-acting injection for the treatment of schizophrenia within specific patient

FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia ...  -  Apr 14, 2007
PipelineReview.com (press release),The new dose of RISPERDAL CONSTA will provide physicians with more options to individualize treatment approaches and adjust therapies when clinical factors

Alkermes Receives FDA Approval For 12.5 Mg Dose Of Risperdal ...  -  Apr 13, 2007
Trading Markets,The company noted that new dose of Risperdal Consta, which is expected to be available by May 1, will be additional options for physicians to individualize

J&J's Jansen Gets New Risperdal Dose OK  -  Apr 13, 2007
Forbes,Johnson & Johnson subsidiary Jansen LP said Friday the Food and Drug Administration approved a new dose of its schizophrenia drug Risperdal Consta.

Janssen's Risperdal OK'd in low dose  -  Apr 13, 2007
United Press InternationalNEWARK, NJ, (UPI) -- US drug maker Janssen said Friday it has been approved to market a new, lower dose of its schizophrenia drug Risperdal Consta.

Schizophrenia drug gets OK for lower dose  -  Apr 15, 2007
NorthJersey.com,The Food and Drug Administration cleared a 12.5 milligram dose of Risperdal Consta, the slow-release, injected version of the medicine, the company,

Alkermes: FDA approves new dose of schizophrenia drug  -  Apr 14, 2007
Milwaukee Business Journal,Alkermes Inc. said Friday the US Food and Drug Administration approved a 12.5 mg dose of Risperdal Consta for the treatment of schizophrenia in specific

Alkermes Gets FDA Nod For New Dose Of Risperidone For ...  -  Apr 13, 2007
Trading Markets,Inc. (ALKS | charts | news | PowerRating) said Friday that the US Food and Drug Administration or the FDA approved a 12.5 mg dose of RISPERDAL CONSTA or

Johnson & Johnson Reports 2007 First-Quarter Results: Sales ...  -  Apr 17, 2007
PR Newswire (press release),Risperdal Consta & Invega * Selected Areas (unaudited) ** Operational growth excludes the effect of currency % Change 2007 YTD 2006 YTD Reported

extracts from the blogosphere  -  Apr 10, 2007
Guardian Unlimited,There's something perverse about a health service that shoves £150 into somebody's arse every time we give them an injection of Risperdal Consta [used to

Analysis: J&J Q1 clouded on stent worries  -  Apr 17, 2007
United Press International...prevention of migraine headaches; Levaquin, an anti-infective, and our anti-psychotic franchise, which includes Risperdal, Risperdal Consta and Invega."

Johnson & Johnson Reports 2007 First-Quarter Results: Sales ...  -  Apr 17, 2007
PharmaLive.com (press release),...prevention of migraine headaches; LEVAQUIN, an anti- infective, and our antipsychotic franchise, which includes RISPERDAL, RISPERDAL CONSTA and INVEGA.

Johnson & Johnson: A Q1 Review  -  Apr 17, 2007
Briefing.com,Key product lines included Topomax, Levaquin, Floxin, and its antipsychotic franchise which includes Risperdal, Risperdal Consta and Invega.

Biotech In Review: Dyax Jumps On Positive Data  -  Apr 15, 2007
Seeking Alpha,Alkermes (ALKS) won approval for a lower dose of Risperdal Consta, a long-acting injection for patients with schizophrenia. The low-dose version is intended

Zacks Analyst Interview Highlights: Alkermes, Johnson & Johnson ...  -  Mar 13, 2007
Business Wire (press release),The company has two approved products on the market: Risperdal Consta for schizophrenia and Vivitrol for alcoholism. Alkermes has a strong alliance with

Alkermes Announces Senior Management Succession Plan  -  Mar 5, 2007
PharmaLive.com (press release),..."We are now a profitable biotechnology company with two breakthrough drugs on the market, RISPERDAL CONSTA and VIVITROL, a strong program in diabetes with

Alkermes names new CEO  -  Mar 5, 2007
Bizjournals.com,Alkermes (Nasdaq: ALKS) currently has two commercial products; Risperdal Consta, a long-acting injection for the treatment of schizophrenia and Vivitrol,

Alkermes Names New CEO  -  Mar 5, 2007
TheStreet.comFor example, the company worked with J&J to create Risperdal Consta, an injectable version of J&J's schizophrenia drug Risperdal.

Alkermes Announces Third Quarter Fiscal 2007 Results  -  Feb 8, 2007
PharmaLive.com (press release),Total manufacturing revenues for the quarter ended December 31, 2006 were $28.8 million, comprised of $23.6 million for RISPERDAL CONSTA and $5.2 million

Outlook Improves at Alkermes  -  Feb 8, 2007
TheStreet.com31, Alkermes overcame continuing disappointing sales of the Vivitrol alcoholism treatment with a big improvement for its Risperdal Consta schizophrenia

Akamai revenue rises 52 percent  -  Feb 7, 2007
Boston Globe,The revenue boost during the quarter was mainly from the manufacturing of Risperdal Consta and Vivitrol for Janssen-Cilag.

Alkermes 3Q Profit Doubles  -  Feb 7, 2007
Forbes,The revenue boost during the quarter came mainly from the manufacturing of Risperdal Consta and Vivitrol for Janssen-Cilag. As of Dec.

Johnson & Johnson: Capitalize On Its Growth  -  Jan 16, 2007
Seeking Alpha,Management believes that the drug will be an improvement upon its currently marketed injectable, Risperdal Consta, which today represents approximately 20%

Alkermes Announces Submission of New Drug Application for ...  -  Dec 20, 2006
PharmaLive.com (press release),RISPERDAL CONSTA is the first and only long-acting, atypical antipsychotic approved by the US Food and Drug Administration and now is approved in more than

Alkermes' Japanese Opportunity  -  Dec 27, 2006
Motley FoolRisperdal Consta is a longer-lasting version of JNJ's Risperdal, which Alkermes helped to develop. As Alkermes' first approved product and one from which it

Alkermes Submits New Drug App in Japan  -  Dec 20, 2006
Houston Chronicle,Risperdal Consta has been approved by the US Food and Drug Administration and now is approved in more than 70 countries worldwide.

Market Report -- In Play (ALKS)  -  Dec 20, 2006
MSN MoneyAlkermes announces submission of New Drug Application for Risperdal Consta in Japan Co announced that the Japanese organization of its partner Janssen-Cilag

Janssen’s Invega approved for schizophrenia  -  Jan 8, 2007
DrugResearcher.com,Janssen will hope that Invega will add to its Risperdal Consta treatment, a long-lasting injection administered every two weeks, which is due for patent

FDA OKs Next-Generation Schizophrenia Med  -  Dec 20, 2006
ABC NewsRisperdal and the injectable long-acting version Risperdal Consta, had combined sales of more than $1 billion in the most recent quarter.

Exacerbation of Psychotic Symptoms Associated With Gatifloxacin  -  Jan 5, 2007
Psychosomatics (subscription)A 62-year-old man with paranoid schizophrenia treated with Risperdal Consta® 25 mg IM q 2 weeks was compliant with treatment and stable enough to live

Developer disappointed with Mass. Turnpike offer  -  Dec 21, 2006
Boston Globe,Risperdal Consta has been approved by the US Food and Drug Administration and now is approved in more than 70 countries. Alkermes said the Japanese unit of

Alkermes' Japanese Opportunity  -  27 Dec 2006
Motley FoolRisperdal Consta is a longer-lasting version of JNJ's Risperdal, which Alkermes helped to develop. As Alkermes' first approved product and one from which it

Alkermes Announces Submission of New Drug Application for ...  -  Dec 20, 2006
PharmaLive.com (press release),RISPERDAL CONSTA is the first and only long-acting, atypical antipsychotic approved by the US Food and Drug Administration and now is approved in more than

Alkermes Submits New Drug App in Japan  -  Dec 20, 2006
Houston Chronicle,Risperdal Consta has been approved by the US Food and Drug Administration and now is approved in more than 70 countries worldwide.

Market Report -- In Play (ALKS)  -  Dec 20, 2006
MSN MoneyAlkermes announces submission of New Drug Application for Risperdal Consta in Japan Co announced that the Japanese organization of its partner Janssen-Cilag

Expectations Deflated for Alkermes  -  Dec 1, 2006
TheStreet.comIn fact, the company's main cash cow is Risperdal Consta, which is the extended two-week injectible version of Johnson & Johnson's (JNJ - commentary

FDA OKs Next-Generation Schizophrenia Med  -  Dec 20, 2006
ABC NewsRisperdal and the injectable long-acting version Risperdal Consta, had combined sales of more than $1 billion in the most recent quarter.

Developer disappointed with Mass. Turnpike offer  -  Dec 21, 2006
Boston Globe,Risperdal Consta has been approved by the US Food and Drug Administration and now is approved in more than 70 countries. Alkermes said the Japanese unit of

Alkermes says study shows promise for drug addiction treatment  -  Dec 4, 2006
Boston Business Journal,Most of the turnaround can be attributed to its first drug release, a schizophrenia treatment called Risperdal Consta.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional